• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC, INC. OPEN PIVOT MECHANICAL HEART VALVE; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC, INC. OPEN PIVOT MECHANICAL HEART VALVE; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 500DM29
Device Problem Detachment of Device or Device Component (2907)
Patient Problem Insufficient Information (4580)
Event Date 09/29/2022
Event Type  Injury  
Manufacturer Narrative
No product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that during the implant of this 29mm mechanical mitral valve, the valve was sutured with braided polyester sutures and was tested for functionality with no issues.Valve leaflet motion was tested using the blue actuator and the valve was rotated within the annulus to obtain appropriate position.After the heart was closed and was taken off bypass, a transesophageal echocardiogram indicated that only one leaflet was visible.The heart was re-opened, bypass was initiated and the valve was explanted.The detached leaflet was unable to be located within the heart.A 27mm valve of the same model was implanted.An additional transesophageal echocardiogram indicated the 27mm was functioning properly.C-arm fluoroscopy was used and could not locate the leaflet within the thoracic or abdominal space.The patient was stable and was transferred to the intensive care unit.Six days post implant imaging confirmed the detached leaflet was in the abdominal aorta.The patient remains at home and stable.No adverse patient effects were reported.
 
Manufacturer Narrative
Product analysis: upon receipt at medtronic's quality laboratory, visual examination revealed that one detached leaflet was received with the valve.The sewing cuff appeared discolored showing evidence of blood contact.The detached leaflet was assessed.A chipped area was noted on the corner of the leaflet.Both leaflets were detached from the orifice therefore a coaptation assessment could not be performed.Both inflow and outflow valve hinge mechanisms appeared intact.The orifice appeared intact with no evidence of damage.Conclusion: the investigation is in progress.A supplemental report will be submitted after completion of the investigation.H3: device evaluated? updated h6: coding updated medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Conclusion: the device history record was reviewed and showed that this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.User / implant techniques such as using other instruments for valve rotation, applied excessive force while rotating the valve leaflets, rotated the valve using the leaflet rather than using the rotator, handling/pulling the valve by grasping the leaflet or holding and compressing (pinching) the valve by contacting the ¿non-pivot areas¿ of the valve could be important contributing factors for leaflet detachment during implant.H6: updated medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPEN PIVOT MECHANICAL HEART VALVE
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer (Section G)
MEDTRONIC, INC.
3800 annapolis lane
minneapolis MN 55447
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key15691935
MDR Text Key302676231
Report Number3008592544-2022-00063
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeRP
PMA/PMN Number
P990046
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number500DM29
Device Catalogue Number500DM29
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/29/2022
Initial Date FDA Received10/28/2022
Supplement Dates Manufacturer Received12/05/2022
02/16/2023
Supplement Dates FDA Received12/21/2022
02/24/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age41 YR
Patient SexFemale
Patient Weight65 KG
-
-